Lynette Chee

1.2k total citations
29 papers, 320 citations indexed

About

Lynette Chee is a scholar working on Hematology, Genetics and Epidemiology. According to data from OpenAlex, Lynette Chee has authored 29 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 11 papers in Genetics and 8 papers in Epidemiology. Recurrent topics in Lynette Chee's work include Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Lynette Chee is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Lynette Chee collaborates with scholars based in Australia, New Zealand and United States. Lynette Chee's co-authors include Karin Thursky, David Ritchie, Monica A. Slavin, Gabrielle M. Haeusler, Rachel Koldej, Benjamin W. Teh, Grant A. McArthur, Andrew Grigg, Louise E. Purton and Jean Hendy and has published in prestigious journals such as Blood, Journal of Leukocyte Biology and British Journal of Haematology.

In The Last Decade

Lynette Chee

25 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynette Chee Australia 9 129 97 68 65 57 29 320
Pınar Ataca Atilla Türkiye 9 200 1.6× 186 1.9× 97 1.4× 65 1.0× 36 0.6× 18 383
Benjamin Watkins United States 10 137 1.1× 54 0.6× 31 0.5× 139 2.1× 31 0.5× 32 319
Johan Törlén Sweden 10 224 1.7× 76 0.8× 46 0.7× 115 1.8× 26 0.5× 16 307
Ioannis Politikos United States 8 173 1.3× 101 1.0× 21 0.3× 61 0.9× 30 0.5× 30 278
Ryoko Yamasaki Japan 11 166 1.3× 116 1.2× 67 1.0× 55 0.8× 40 0.7× 33 314
Albert Esquirol Spain 13 297 2.3× 199 2.1× 73 1.1× 75 1.2× 41 0.7× 45 433
Yuewen Fu China 9 147 1.1× 68 0.7× 50 0.7× 51 0.8× 29 0.5× 40 265
Irene García‐Cadenas Spain 11 270 2.1× 198 2.0× 94 1.4× 84 1.3× 33 0.6× 45 407
Kazuo Hatanaka Japan 10 157 1.2× 77 0.8× 31 0.5× 51 0.8× 25 0.4× 33 264
B-M Svahn Sweden 7 278 2.2× 92 0.9× 55 0.8× 72 1.1× 23 0.4× 7 393

Countries citing papers authored by Lynette Chee

Since Specialization
Citations

This map shows the geographic impact of Lynette Chee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette Chee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette Chee more than expected).

Fields of papers citing papers by Lynette Chee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynette Chee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette Chee. The network helps show where Lynette Chee may publish in the future.

Co-authorship network of co-authors of Lynette Chee

This figure shows the co-authorship network connecting the top 25 collaborators of Lynette Chee. A scholar is included among the top collaborators of Lynette Chee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynette Chee. Lynette Chee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puerta‐Alcalde, Pedro, James H. O’Keefe, Néstor López, et al.. (2025). Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study. International Journal of Infectious Diseases. 153. 107785–107785.
3.
Chee, Lynette, Ann S. J. Yeoh, Matan Thangavelu Thangavelu, et al.. (2025). Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype. Cell Death and Disease. 16(1). 529–529. 2 indexed citations
4.
Chee, Lynette, Nora Lee, Andrew Grigg, et al.. (2024). Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia. Internal Medicine Journal. 54(7). 1214–1218. 2 indexed citations
5.
Giagounidis, Aristoteles, Thomas Cluzeau, María Díez‐Campelo, et al.. (2023). S166: KER-050 TREATMENT IMPROVED MARKERS OF ERYTHROPOIETIC ACTIVITY AND HEMATOPOIESIS OVER SIX MONTHS WHICH RESULTED IN HEMATOLOGICAL RESPONSES ACROSS A BROAD, LOWER-RISK MDS POPULATION. HemaSphere. 7(S3). e335221a–e335221a.
7.
Díez‐Campelo, María, David M. Ross, Aristoteles Giagounidis, et al.. (2023). Durable Clinical Benefit with Ker-050 Treatment: Findings from an Ongoing Phase 2 Study in Participants with Lower-Risk MDS. Blood. 142(Supplement 1). 196–196. 6 indexed citations
8.
Harrison, Claire, David M. Ross, Lynette Chee, et al.. (2023). Modulation of TGF-β Superfamily Signaling By Ker-050 Demonstrated Potential to Treat Myelofibrosis and Mitigate Ruxolitinib-Associated Cytopenia. Blood. 142(Supplement 1). 3185–3185. 2 indexed citations
9.
Koldej, Rachel, et al.. (2022). Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review. Bone Marrow Transplantation. 57(10). 1489–1499. 3 indexed citations
10.
Enjeti, Anoop, Rishu Agarwal, Piers Blombery, et al.. (2022). Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement. Pathology. 54(4). 389–398. 3 indexed citations
11.
Kliman, David, Glen Kennedy, Cameron Curley, et al.. (2022). The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR. Bone Marrow Transplantation. 57(6). 982–989. 3 indexed citations
12.
Lindsay, Julian, Jad Othman, Michelle K. Yong, et al.. (2021). Dynamics of Epstein–Barr virus on post‐transplant lymphoproliferative disorders after antithymocyte globulin‐conditioned allogeneic hematopoietic cell transplant. Transplant Infectious Disease. 23(5). e13719–e13719. 7 indexed citations
13.
Ross, David M., Nada Hamad, Steven Lane, et al.. (2021). Myeloid somatic mutation panel testing in myeloproliferative neoplasms. Pathology. 53(3). 339–348. 11 indexed citations
14.
Ananda‐Rajah, Michelle, Sarah Kidd, Eloise Williams, et al.. (2021). Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021. Internal Medicine Journal. 51(S7). 18–36. 30 indexed citations
15.
Haeusler, Gabrielle M., et al.. (2020). CAR-T cell therapy and infection: a review. Expert Review of Anti-infective Therapy. 19(6). 749–758. 66 indexed citations
18.
Chee, Lynette, Jean Hendy, Louise E. Purton, & Grant A. McArthur. (2012). ATRA and the specific RARα agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells. Leukemia. 27(6). 1369–1380. 18 indexed citations
19.
Chee, Lynette, et al.. (2008). Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies. Journal of Infection. 56(4). 227–233. 25 indexed citations
20.
Chee, Lynette, et al.. (2006). Relapsed blastic natural killer cell leukaemia with splenic rupture. British Journal of Haematology. 135(1). 2–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026